Association between variants in TCF7L2 , CTRB1/2 , and GLP-1R genes and response to therapy with glucagon-like peptide-1 receptor agonists-Reference-Cited by-同舟云学术

Association between variants in TCF7L2 , CTRB1/2 , and GLP-1R genes and response to therapy with glucagon-like peptide-1 receptor agonists

Published:2024-02-17 Issue:2 Volume:136 Page:218-225
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Kyriakidou Artemis¹^ORCID,Kyriazou Angeliki V.¹,Koufakis Theocharis²^ORCID,Vasilopoulos Yiannis³^ORCID,Avramidis Iakovos⁴^ORCID,Baltagiannis Stefanos⁵,Goulis Dimitrios G.⁶^ORCID,Kotsa Kalliopi¹^ORCID

Affiliation:

1. Division of Endocrinology and Metabolism - Diabetes Center, 1st Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA University Hospital, Thessaloniki, Greece

2. Second Propaedeutic Department of Internal Medicine, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece

3. Department of Biology, Section of Genetics, Cell Biology and Development, University of Patras, Patras, Greece

4. Diabetes Center, Department of Internal Medicine, G. Papanikolaou General Hospital, Thessaloniki, Greece

5. Diabetes Outpatient Clinic, General Hospital of Kastoria, Kastoria, Greece

6. Unit of Reproductive Endocrinology, 1st Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece

Funder

Novo Nordisk

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2024.2328513

Reference31 articles.

1. GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art

2. Pharmacogenetics of Glucagon-like Peptide-1 Agonists for the Treatment of Type 2 Diabetes Mellitus

3. Pharmacogenetics of the Glucagon-like Peptide-1 Receptor Agonist Liraglutide: A Step Towards Personalized Type 2 Diabetes Management

4. Pharmacogenomics of GLP-1 receptor agonists: Focus on pharmacological profile

5. Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of GLP-1 receptor agonists on obesity in patients with severe mental illness: A state hospital case series of clozapine-treated patients;Psychiatry Research Case Reports;2024-12

2. SGLT2 inhibitors: A groundbreaking class of cardiovascular drugs, but who benefits most?;International Journal of Cardiology;2024-10

3. Computational approaches for clinical, genomic and proteomic markers of response to glucagon-like peptide-1 therapy in type-2 diabetes mellitus: An exploratory analysis with machine learning algorithms;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-07